Table of Content

1 Ocular Drug Delivery Market Overview
1.1 Ocular Drug Delivery Product Scope
1.2 Ocular Drug Delivery Segment by Type
1.2.1 Global Ocular Drug Delivery Sales by Type (2016 & 2021 & 2027)
1.2.2 Ocular Insert
1.2.3 Iontophoresis
1.2.4 Intraocular Implants
1.2.5 In Situ Gel & Punctal Plugs
1.2.6 Others
1.3 Ocular Drug Delivery Segment by Application
1.3.1 Global Ocular Drug Delivery Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Ophthalmic Clinics
1.3.5 Homecare Settings
1.4 Ocular Drug Delivery Market Estimates and Forecasts (2016-2027)
1.4.1 Global Ocular Drug Delivery Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Ocular Drug Delivery Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Ocular Drug Delivery Price Trends (2016-2027)

2 Ocular Drug Delivery Estimates and Forecasts by Region
2.1 Global Ocular Drug Delivery Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Ocular Drug Delivery Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Ocular Drug Delivery Sales Market Share by Region (2016-2021)
2.2.2 Global Ocular Drug Delivery Revenue Market Share by Region (2016-2021)
2.3 Global Ocular Drug Delivery Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Ocular Drug Delivery Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Ocular Drug Delivery Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Ocular Drug Delivery Estimates and Projections (2016-2027)
2.4.2 Europe Ocular Drug Delivery Estimates and Projections (2016-2027)
2.4.3 China Ocular Drug Delivery Estimates and Projections (2016-2027)
2.4.4 Japan Ocular Drug Delivery Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Ocular Drug Delivery Estimates and Projections (2016-2027)
2.4.6 India Ocular Drug Delivery Estimates and Projections (2016-2027)

3 Global Ocular Drug Delivery Competition Landscape by Players
3.1 Global Top Ocular Drug Delivery Players by Sales (2016-2021)
3.2 Global Top Ocular Drug Delivery Players by Revenue (2016-2021)
3.3 Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ocular Drug Delivery as of 2020)
3.4 Global Ocular Drug Delivery Average Price by Company (2016-2021)
3.5 Manufacturers Ocular Drug Delivery Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Ocular Drug Delivery Market Size by Type
4.1 Global Ocular Drug Delivery Historic Market Review by Type (2016-2021)
4.1.1 Global Ocular Drug Delivery Sales Market Share by Type (2016-2021)
4.1.2 Global Ocular Drug Delivery Revenue Market Share by Type (2016-2021)
4.1.3 Global Ocular Drug Delivery Price by Type (2016-2021)
4.2 Global Ocular Drug Delivery Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Ocular Drug Delivery Sales Forecast by Type (2022-2027)
4.2.2 Global Ocular Drug Delivery Revenue Forecast by Type (2022-2027)
4.2.3 Global Ocular Drug Delivery Price Forecast by Type (2022-2027)

5 Global Ocular Drug Delivery Market Size by Application
5.1 Global Ocular Drug Delivery Historic Market Review by Application (2016-2021)
5.1.1 Global Ocular Drug Delivery Sales Market Share by Application (2016-2021)
5.1.2 Global Ocular Drug Delivery Revenue Market Share by Application (2016-2021)
5.1.3 Global Ocular Drug Delivery Price by Application (2016-2021)
5.2 Global Ocular Drug Delivery Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Ocular Drug Delivery Sales Forecast by Application (2022-2027)
5.2.2 Global Ocular Drug Delivery Revenue Forecast by Application (2022-2027)
5.2.3 Global Ocular Drug Delivery Price Forecast by Application (2022-2027)

6 North America Ocular Drug Delivery Market Facts & Figures
6.1 North America Ocular Drug Delivery Sales by Company
6.1.1 North America Ocular Drug Delivery Sales by Company (2016-2021)
6.1.2 North America Ocular Drug Delivery Revenue by Company (2016-2021)
6.2 North America Ocular Drug Delivery Sales Breakdown by Type
6.2.1 North America Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
6.2.2 North America Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
6.3 North America Ocular Drug Delivery Sales Breakdown by Application
6.3.1 North America Ocular Drug Delivery Sales Breakdown by Application (2016-2021)
6.3.2 North America Ocular Drug Delivery Sales Breakdown by Application (2022-2027)

7 Europe Ocular Drug Delivery Market Facts & Figures
7.1 Europe Ocular Drug Delivery Sales by Company
7.1.1 Europe Ocular Drug Delivery Sales by Company (2016-2021)
7.1.2 Europe Ocular Drug Delivery Revenue by Company (2016-2021)
7.2 Europe Ocular Drug Delivery Sales Breakdown by Type
7.2.1 Europe Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
7.2.2 Europe Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
7.3 Europe Ocular Drug Delivery Sales Breakdown by Application
7.3.1 Europe 125 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 125 Sales Breakdown by Application (2022-2027)

8 China Ocular Drug Delivery Market Facts & Figures
8.1 China Ocular Drug Delivery Sales by Company
8.1.1 China Ocular Drug Delivery Sales by Company (2016-2021)
8.1.2 China Ocular Drug Delivery Revenue by Company (2016-2021)
8.2 China Ocular Drug Delivery Sales Breakdown by Type
8.2.1 China Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
8.2.2 China Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
8.3 China Ocular Drug Delivery Sales Breakdown by Application
8.3.1 China 154 Sales Breakdown by Application (2016-2021)
8.3.2 China 154 Sales Breakdown by Application (2022-2027)

9 Japan Ocular Drug Delivery Market Facts & Figures
9.1 Japan Ocular Drug Delivery Sales by Company
9.1.1 Japan Ocular Drug Delivery Sales by Company (2016-2021)
9.1.2 Japan Ocular Drug Delivery Revenue by Company (2016-2021)
9.2 Japan Ocular Drug Delivery Sales Breakdown by Type
9.2.1 Japan Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
9.2.2 Japan Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
9.3 Japan Ocular Drug Delivery Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Ocular Drug Delivery Market Facts & Figures
10.1 Southeast Asia Ocular Drug Delivery Sales by Company
10.1.1 Southeast Asia Ocular Drug Delivery Sales by Company (2016-2021)
10.1.2 Southeast Asia Ocular Drug Delivery Revenue by Company (2016-2021)
10.2 Southeast Asia Ocular Drug Delivery Sales Breakdown by Type
10.2.1 Southeast Asia Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Ocular Drug Delivery Sales Breakdown by Application
10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)

11 India Ocular Drug Delivery Market Facts & Figures
11.1 India Ocular Drug Delivery Sales by Company
11.1.1 India Ocular Drug Delivery Sales by Company (2016-2021)
11.1.2 India Ocular Drug Delivery Revenue by Company (2016-2021)
11.2 India Ocular Drug Delivery Sales Breakdown by Type
11.2.1 India Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
11.2.2 India Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
11.3 India Ocular Drug Delivery Sales Breakdown by Application
11.3.1 India Ocular Drug Delivery Sales Breakdown by Application (2016-2021)
11.3.2 India Ocular Drug Delivery Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Ocular Drug Delivery Business
12.1 OCULAR THERAPEUTIX, INC
12.1.1 OCULAR THERAPEUTIX, INC Corporation Information
12.1.2 OCULAR THERAPEUTIX, INC Business Overview
12.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Products Offered
12.1.5 OCULAR THERAPEUTIX, INC Recent Development
12.2 Alimera Sciences
12.2.1 Alimera Sciences Corporation Information
12.2.2 Alimera Sciences Business Overview
12.2.3 Alimera Sciences Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Alimera Sciences Ocular Drug Delivery Products Offered
12.2.5 Alimera Sciences Recent Development
12.3 Allergan, Plc
12.3.1 Allergan, Plc Corporation Information
12.3.2 Allergan, Plc Business Overview
12.3.3 Allergan, Plc Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Allergan, Plc Ocular Drug Delivery Products Offered
12.3.5 Allergan, Plc Recent Development
12.4 EyeGate Pharma
12.4.1 EyeGate Pharma Corporation Information
12.4.2 EyeGate Pharma Business Overview
12.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.4.4 EyeGate Pharma Ocular Drug Delivery Products Offered
12.4.5 EyeGate Pharma Recent Development
12.5 Valeant Pharmaceuticals International, Inc
12.5.1 Valeant Pharmaceuticals International, Inc Corporation Information
12.5.2 Valeant Pharmaceuticals International, Inc Business Overview
12.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Products Offered
12.5.5 Valeant Pharmaceuticals International, Inc Recent Development
12.6 Envisia Therapeutics
12.6.1 Envisia Therapeutics Corporation Information
12.6.2 Envisia Therapeutics Business Overview
12.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Envisia Therapeutics Ocular Drug Delivery Products Offered
12.6.5 Envisia Therapeutics Recent Development
12.7 Clearside Biomedical
12.7.1 Clearside Biomedical Corporation Information
12.7.2 Clearside Biomedical Business Overview
12.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Clearside Biomedical Ocular Drug Delivery Products Offered
12.7.5 Clearside Biomedical Recent Development
12.8 Graybug Vision Inc
12.8.1 Graybug Vision Inc Corporation Information
12.8.2 Graybug Vision Inc Business Overview
12.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Graybug Vision Inc Ocular Drug Delivery Products Offered
12.8.5 Graybug Vision Inc Recent Development
12.9 Taiwan Liposome Company
12.9.1 Taiwan Liposome Company Corporation Information
12.9.2 Taiwan Liposome Company Business Overview
12.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Taiwan Liposome Company Ocular Drug Delivery Products Offered
12.9.5 Taiwan Liposome Company Recent Development
12.10 Santen Pharmaceutical
12.10.1 Santen Pharmaceutical Corporation Information
12.10.2 Santen Pharmaceutical Business Overview
12.10.3 Santen Pharmaceutical Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Santen Pharmaceutical Ocular Drug Delivery Products Offered
12.10.5 Santen Pharmaceutical Recent Development

13 Ocular Drug Delivery Manufacturing Cost Analysis
13.1 Ocular Drug Delivery Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Ocular Drug Delivery
13.4 Ocular Drug Delivery Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Ocular Drug Delivery Distributors List
14.3 Ocular Drug Delivery Customers

15 Market Dynamics
15.1 Ocular Drug Delivery Market Trends
15.2 Ocular Drug Delivery Drivers
15.3 Ocular Drug Delivery Market Challenges
15.4 Ocular Drug Delivery Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Ocular Drug Delivery Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Ocular Drug Delivery Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Ocular Drug Delivery Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Ocular Drug Delivery Sales (K Doses) by Region (2016-2021)
Table 5. Global Ocular Drug Delivery Sales Market Share by Region (2016-2021)
Table 6. Global Ocular Drug Delivery Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Ocular Drug Delivery Revenue Share by Region (2016-2021)
Table 8. Global Ocular Drug Delivery Sales (K Doses) Forecast by Region (2022-2027)
Table 9. Global Ocular Drug Delivery Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Ocular Drug Delivery Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Ocular Drug Delivery Revenue Share Forecast by Region (2022-2027)
Table 12. Global Ocular Drug Delivery Sales (K Doses) of Key Companies (2016-2021)
Table 13. Global Ocular Drug Delivery Sales Share by Company (2016-2021)
Table 14. Global Ocular Drug Delivery Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Ocular Drug Delivery Revenue Share by Company (2016-2021)
Table 16. Global Ocular Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ocular Drug Delivery as of 2020)
Table 17. Global Ocular Drug Delivery Average Price (USD/Dose) of Key Company (2016-2021)
Table 18. Manufacturers Ocular Drug Delivery Manufacturing Sites and Area Served
Table 19. Manufacturers Ocular Drug Delivery Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Ocular Drug Delivery Sales (K Doses) by Type (2016-2021)
Table 22. Global Ocular Drug Delivery Sales Share by Type (2016-2021)
Table 23. Global Ocular Drug Delivery Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Ocular Drug Delivery Price (USD/Dose) by Type (2016-2021)
Table 25. Global Ocular Drug Delivery Sales Share by Type (2022-2027)
Table 26. Global Ocular Drug Delivery Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Ocular Drug Delivery Revenue Share by Type (2022-2027)
Table 28. Global Ocular Drug Delivery Price (USD/Dose) by Type (2022-2027)
Table 29. Global Ocular Drug Delivery Sales (K Doses) by Application (2016-2021)
Table 30. Global Ocular Drug Delivery Sales Share by Application (2016-2021)
Table 31. Global Ocular Drug Delivery Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Ocular Drug Delivery Price (USD/Dose) by Application (2016-2021)
Table 33. Global Ocular Drug Delivery Sales (K Doses) by Application (2022-2027)
Table 34. Global Ocular Drug Delivery Sales Share by Application (2022-2027)
Table 35. Global Ocular Drug Delivery Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Ocular Drug Delivery Revenue Share by Application (2022-2027)
Table 37. Global Ocular Drug Delivery Price (USD/Dose) by Application (2022-2027)
Table 38. North America Ocular Drug Delivery Sales (K Doses) by Company (2016-2021)
Table 39. North America Ocular Drug Delivery Sales Market Share by Company (2016-2021)
Table 40. North America Ocular Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Ocular Drug Delivery Revenue Market Share by Company (2016-2021)
Table 42. North America Ocular Drug Delivery Sales by Type (2016-2021) & (K Doses)
Table 43. North America Ocular Drug Delivery Sales Market Share by Type (2016-2021)
Table 44. North America Ocular Drug Delivery Sales by Type (2022-2027) & (K Doses)
Table 45. North America Ocular Drug Delivery Sales Market Share by Type (2022-2027)
Table 46. North America Ocular Drug Delivery Sales by Application (2016-2021) & (K Doses)
Table 47. North America Ocular Drug Delivery Sales Market Share by Application (2016-2021)
Table 48. North America Ocular Drug Delivery Sales by Application (2022-2027) & (K Doses)
Table 49. North America Ocular Drug Delivery Sales Market Share by Application (2022-2027)
Table 50. Europe Ocular Drug Delivery Sales (K Doses) by Company (2016-2021)
Table 51. Europe Ocular Drug Delivery Sales Market Share by Company (2016-2021)
Table 52. Europe Ocular Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Ocular Drug Delivery Revenue Market Share by Company (2016-2021)
Table 54. Europe Ocular Drug Delivery Sales by Type (2016-2021) & (K Doses)
Table 55. Europe Ocular Drug Delivery Sales Market Share by Type (2016-2021)
Table 56. Europe Ocular Drug Delivery Sales by Type (2022-2027) & (K Doses)
Table 57. Europe Ocular Drug Delivery Sales Market Share by Type (2022-2027)
Table 58. Europe Ocular Drug Delivery Sales by Application (2016-2021) & (K Doses)
Table 59. Europe Ocular Drug Delivery Sales Market Share by Application (2016-2021)
Table 60. Europe Ocular Drug Delivery Sales by Application (2022-2027) & (K Doses)
Table 61. Europe Ocular Drug Delivery Sales Market Share by Application (2022-2027)
Table 62. China Ocular Drug Delivery Sales (K Doses) by Company (2016-2021)
Table 63. China Ocular Drug Delivery Sales Market Share by Company (2016-2021)
Table 64. China Ocular Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Ocular Drug Delivery Revenue Market Share by Company (2016-2021)
Table 66. China Ocular Drug Delivery Sales by Type (2016-2021) & (K Doses)
Table 67. China Ocular Drug Delivery Sales Market Share by Type (2016-2021)
Table 68. China Ocular Drug Delivery Sales by Type (2022-2027) & (K Doses)
Table 69. China Ocular Drug Delivery Sales Market Share by Type (2022-2027)
Table 70. China Ocular Drug Delivery Sales by Application (2016-2021) & (K Doses)
Table 71. China Ocular Drug Delivery Sales Market Share by Application (2016-2021)
Table 72. China Ocular Drug Delivery Sales by Application (2022-2027) & (K Doses)
Table 73. China Ocular Drug Delivery Sales Market Share by Application (2022-2027)
Table 74. Japan Ocular Drug Delivery Sales (K Doses) by Company (2016-2021)
Table 75. Japan Ocular Drug Delivery Sales Market Share by Company (2016-2021)
Table 76. Japan Ocular Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Ocular Drug Delivery Revenue Market Share by Company (2016-2021)
Table 78. Japan Ocular Drug Delivery Sales by Type (2016-2021) & (K Doses)
Table 79. Japan Ocular Drug Delivery Sales Market Share by Type (2016-2021)
Table 80. Japan Ocular Drug Delivery Sales by Type (2022-2027) & (K Doses)
Table 81. Japan Ocular Drug Delivery Sales Market Share by Type (2022-2027)
Table 82. Japan Ocular Drug Delivery Sales by Application (2016-2021) & (K Doses)
Table 83. Japan Ocular Drug Delivery Sales Market Share by Application (2016-2021)
Table 84. Japan Ocular Drug Delivery Sales by Application (2022-2027) & (K Doses)
Table 85. Japan Ocular Drug Delivery Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Ocular Drug Delivery Sales (K Doses) by Company (2016-2021)
Table 87. Southeast Asia Ocular Drug Delivery Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Ocular Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Ocular Drug Delivery Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Ocular Drug Delivery Sales by Type (2016-2021) & (K Doses)
Table 91. Southeast Asia Ocular Drug Delivery Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Ocular Drug Delivery Sales by Type (2022-2027) & (K Doses)
Table 93. Southeast Asia Ocular Drug Delivery Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Ocular Drug Delivery Sales by Application (2016-2021) & (K Doses)
Table 95. Southeast Asia Ocular Drug Delivery Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Ocular Drug Delivery Sales by Application (2022-2027) & (K Doses)
Table 97. Southeast Asia Ocular Drug Delivery Sales Market Share by Application (2022-2027)
Table 98. India Ocular Drug Delivery Sales (K Doses) by Company (2016-2021)
Table 99. India Ocular Drug Delivery Sales Market Share by Company (2016-2021)
Table 100. India Ocular Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Ocular Drug Delivery Revenue Market Share by Company (2016-2021)
Table 102. India Ocular Drug Delivery Sales by Type (2016-2021) & (K Doses)
Table 103. India Ocular Drug Delivery Sales Market Share by Type (2016-2021)
Table 104. India Ocular Drug Delivery Sales by Type (2022-2027) & (K Doses)
Table 105. India Ocular Drug Delivery Sales Market Share by Type (2022-2027)
Table 106. India Ocular Drug Delivery Sales by Application (2016-2021) & (K Doses)
Table 107. India Ocular Drug Delivery Sales Market Share by Application (2016-2021)
Table 108. India Ocular Drug Delivery Sales by Application (2022-2027) & (K Doses)
Table 109. India Ocular Drug Delivery Sales Market Share by Application (2022-2027)
Table 110. OCULAR THERAPEUTIX, INC Corporation Information
Table 111. OCULAR THERAPEUTIX, INC Description and Business Overview
Table 112. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product
Table 114. OCULAR THERAPEUTIX, INC Recent Development
Table 115. Alimera Sciences Corporation Information
Table 116. Alimera Sciences Description and Business Overview
Table 117. Alimera Sciences Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Alimera Sciences Ocular Drug Delivery Product
Table 119. Alimera Sciences Recent Development
Table 120. Allergan, Plc Corporation Information
Table 121. Allergan, Plc Description and Business Overview
Table 122. Allergan, Plc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. Allergan, Plc Ocular Drug Delivery Product
Table 124. Allergan, Plc Recent Development
Table 125. EyeGate Pharma Corporation Information
Table 126. EyeGate Pharma Description and Business Overview
Table 127. EyeGate Pharma Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. EyeGate Pharma Ocular Drug Delivery Product
Table 129. EyeGate Pharma Recent Development
Table 130. Valeant Pharmaceuticals International, Inc Corporation Information
Table 131. Valeant Pharmaceuticals International, Inc Description and Business Overview
Table 132. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Product
Table 134. Valeant Pharmaceuticals International, Inc Recent Development
Table 135. Envisia Therapeutics Corporation Information
Table 136. Envisia Therapeutics Description and Business Overview
Table 137. Envisia Therapeutics Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. Envisia Therapeutics Ocular Drug Delivery Product
Table 139. Envisia Therapeutics Recent Development
Table 140. Clearside Biomedical Corporation Information
Table 141. Clearside Biomedical Description and Business Overview
Table 142. Clearside Biomedical Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. Clearside Biomedical Ocular Drug Delivery Product
Table 144. Clearside Biomedical Recent Development
Table 145. Graybug Vision Inc Corporation Information
Table 146. Graybug Vision Inc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 147. Graybug Vision Inc Description and Business Overview
Table 148. Graybug Vision Inc Ocular Drug Delivery Product
Table 149. Graybug Vision Inc Recent Development
Table 150. Taiwan Liposome Company Corporation Information
Table 151. Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 152. Taiwan Liposome Company Description and Business Overview
Table 153. Taiwan Liposome Company Ocular Drug Delivery Product
Table 154. Taiwan Liposome Company Recent Development
Table 155. Santen Pharmaceutical Corporation Information
Table 156. Santen Pharmaceutical Description and Business Overview
Table 157. Santen Pharmaceutical Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 158. Santen Pharmaceutical Ocular Drug Delivery Product
Table 159. Santen Pharmaceutical Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Ocular Drug Delivery Distributors List
Table 163. Ocular Drug Delivery Customers List
Table 164. Ocular Drug Delivery Market Trends
Table 165. Ocular Drug Delivery Market Drivers
Table 166. Ocular Drug Delivery Market Challenges
Table 167. Ocular Drug Delivery Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Ocular Drug Delivery Product Picture
Figure 2. Global Ocular Drug Delivery Sales Market Share by Type in 2021 & 2027
Figure 3. Ocular Insert Product Picture
Figure 4. Iontophoresis Product Picture
Figure 5. Intraocular Implants Product Picture
Figure 6. In Situ Gel & Punctal Plugs Product Picture
Figure 7. Others Product Picture
Figure 8. Global Ocular Drug Delivery Sales Market Share by Application in 2021 & 2027
Figure 9. Hospitals Examples
Figure 10. Ambulatory Surgical Centers Examples
Figure 11. Ophthalmic Clinics Examples
Figure 12. Homecare Settings Examples
Figure 13. Global Ocular Drug Delivery Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Ocular Drug Delivery Sales Growth Rate (2016-2027) & (US$ Million)
Figure 15. Global Ocular Drug Delivery Sales (K Doses) Growth Rate (2016-2027)
Figure 16. Global Ocular Drug Delivery Price Trends Growth Rate (2016-2027) (USD/Dose)
Figure 17. Global Ocular Drug Delivery Revenue Market Share by Region: 2016 VS 2021
Figure 18. Global Ocular Drug Delivery Revenue Market Share by Region: 2021 VS 2027
Figure 19. North America Ocular Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. North America Ocular Drug Delivery Sales (K Doses) Growth Rate (2016-2027)
Figure 21. Europe Ocular Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Europe Ocular Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 23. China Ocular Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. China Ocular Drug Delivery Sales (Million USD) and Growth Rate (2016-2027)
Figure 25. Japan Ocular Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Japan Ocular Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Ocular Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Ocular Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 29. India Ocular Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. India Ocular Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 31. Global 5 Largest Ocular Drug Delivery Players Market Share by Revenue in Ocular Drug Delivery: 2016 & 2020
Figure 32. Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 33. Global Ocular Drug Delivery Revenue Share by Type (2016-2021)
Figure 34. Global Ocular Drug Delivery Revenue Growth Rate by Type in 2016 & 2020
Figure 35. Global Ocular Drug Delivery Revenue Share by Application (2016-2021)
Figure 36. Global Ocular Drug Delivery Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Ocular Drug Delivery Sales Market Share by Type in 2020
Figure 38. North America Ocular Drug Delivery Sales Market Share by Application in 2020
Figure 39. Europe Ocular Drug Delivery Sales Market Share by Type in 2020
Figure 40. Europe Ocular Drug Delivery Sales Market Share by Application in 2020
Figure 41. China Ocular Drug Delivery Sales Market Share by Type in 2020
Figure 42. China Ocular Drug Delivery Sales Market Share by Application in 2020
Figure 43. Japan Ocular Drug Delivery Sales Market Share by Type in 2020
Figure 44. Japan Ocular Drug Delivery Sales Market Share by Application in 2020
Figure 45. Southeast Asia Ocular Drug Delivery Sales Market Share by Type in 2020
Figure 46. Southeast Asia Ocular Drug Delivery Sales Market Share by Application in 2020
Figure 47. India Ocular Drug Delivery Sales Market Share by Type in 2020
Figure 48. India Ocular Drug Delivery Sales Market Share by Application in 2020
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Ocular Drug Delivery
Figure 51. Manufacturing Process Analysis of Ocular Drug Delivery
Figure 52. Ocular Drug Delivery Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed